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Pax3 and Pax7 regulate stem cell function in skeletal
myogenesis. However, molecular insight into their
distinct roles has remained elusive. Using gene
expression data combined with genome-wide
binding-site analysis, we show that both Pax3 and
Pax7 bind identical DNA motifs and jointly activate
a large panel of genes involved in muscle stem cell
function. Surprisingly, in adult myoblasts Pax3 binds
a subset (6.4%) of Pax7 targets. Despite a significant
overlap in their transcriptional network, Pax7 regu-
lates distinct panels of genes involved in the pro-
motion of proliferation and inhibition of myogenic
differentiation. We show that Pax7 has a higher
binding affinity to the homeodomain-binding motif
relative to Pax3, suggesting that intrinsic differences
in DNA binding contribute to the observed functional
difference between Pax3 and Pax7 binding in myo-
genesis. Together, our data demonstrate distinct
attributes of Pax7 function and provide mechanistic
insight into the nonredundancy of Pax3 and Pax7 in
muscle development.
INTRODUCTION
The maintenance and repair of adult muscle tissue is directed by
satellite cells. Quiescent satellite cells are activated by exercise
or injury and enter the cell cycle to produce progeny myogenic
precursor cells that undergo multiple rounds of division before
entering terminal differentiation and fusing tomultinucleatedmy-
ofibers (Charge´ and Rudnicki, 2004). Moreover, satellite cells
exist as a heterogeneous population based onMyf5 expression,
a feature that divides the satellite cell pool into a subpopulation
of self-renewing stem cells (Myf5) and committed progenitors
(Myf5+) (Kuang et al., 2007).
Satellite cells express the paired box transcription factors
Pax3 and Pax7, which lie genetically upstream of the myogenic1208 Developmental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevregulatory factors (MRFs) MyoD and Myf5 (Buckingham and
Relaix, 2007). Pax7 is uniformly expressed at high levels in satel-
lite cells and plays a critical role in regulating their function. By
contrast, equivalent level of Pax3 is expressed in satellite cells
in a subset of muscles such as diaphragm, but satellite cells in
most muscle groups express very low levels (Kassar-Duchossoy
et al., 2005). Extensive analyses of Pax7/mice have confirmed
the progressive loss of the satellite cell lineage inmultiple muscle
groups (Kuang et al., 2006; Oustanina et al., 2004; Relaix et al.,
2006; Seale et al., 2000). Small numbers of Pax7-deficient cells
do survive in the satellite cell position but these cells are pro-
gressively lost, likely due to survival deficits or precocious differ-
entiation.Pax7/muscles are reduced in size, the fibers contain
approximately 50% the normal number of nuclei, and fiber diam-
eters are significantly reduced (Kuang et al., 2006). Notably,
Pax7 dependency in satellite cells has been suggested to be
limited to a critical juvenile period when satellite cells are transi-
tioning to a quiescent state (Lepper et al., 2009).
Our current understanding is that Pax3 and Pax7 play some
overlapping but mostly nonredundant roles in the specification
and progression of the adult satellite cell lineage. During early
myogenesis, Pax3 and Pax7 expression defines a population
of embryonic progenitors that have been suggested to later
give rise to satellite cells. In the absence of both Pax3/7, these
progenitors undergo apoptosis, or adopt alternative nonmyo-
genic cell fates (Kassar-Duchossoy et al., 2005; Relaix et al.,
2005). However, Pax3 expression does not rescue the loss of
Pax7 in adult satellite cells. For example, while Pax3-expressing
cells are found in the limb muscles of Pax7/ mice and express
MyoD, these cells are progressively lost, display poor myogenic
potential, and are located in the interstitial space rather than the
satellite cell niche (Kuang et al., 2006; Relaix et al., 2006).
Notably, satellite cells in the diaphragm express high levels of
Pax3, but nonetheless, in Pax7/ mice are similarly lost leading
to progressive muscle wasting in the same manner as other
muscle groups (Seale et al., 2000). Together, these data under-
score the nonredundant functions of Pax3 and Pax7 in the
myogenic program.
The transcriptional network that controls satellite cell lineage
progression is similar to that deployed during embryonic
myogenesis. During development, Pax3 has been shown to beier Inc.
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Figure 1. Pax3 Binds a Subset of Pax7 Binding Sites
(A) Overexpression of Pax7- and Pax3-CTAP in primary myoblasts reveals a reduction in endogenous levels of Pax7. Pax3 is not expressed in control cells. Also
see Figure S1 for a quantitative estimate of proviral versus endogenous Pax7 protein measured as number of molecules per cell.
(B) Analysis of peak locations relative to gene start sites indicates Pax3 and Pax7 binding is predominantly in intergenic or intronic regions.
(C) Overlap of Pax3 and Pax7 peak data reveals that Pax3 binds only 6.4% of Pax7 sites.
(D) Comparison of peaks subsets for Pax3 and Pax7 indicates a stronger binding of Pax7 to DNA in adult skeletal muscle cells as shown by the MACS (Zhang
et al., 2008) scores, calculated as 10 3 log10 (p value of the peaks).
(E) Plot of Pax3 versus Pax7 reads in common peaks shows that Pax7 peaks have generally higher sequence reads than Pax3 counterparts. Counts in the legend
indicate number of peaks.
See also Figure S1 and Tables S1 and S2.
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Distinct Function of Pax7 in Adult Myogenesisinvolved in the delamination and migration of embryonic
myoblasts toward developing limb buds (Bober et al., 1994).
Pax3 can also directly activate Myf5 and MyoD in the embryo,
thereby initiating myogenic differentiation (Punch et al., 2009).
Embryonic progenitors that give rise to satellite cells are charac-
terized by Pax3/Pax7 expression and the lack of expression of
other myogenic regulatory factors (MRFs: Myf5, MyoD, Mrf4,
and Myogenin). Pax3/7+ cells enter the myogenic program by
upregulation of Myf5/MyoD, or give rise to satellite cells during
late fetal myogenesis without upregulating MRFs. Pax3/
7+MRF progenitors are first found to align with nascent myo-
tubes at E15.5, then become satellite cells by taking a sublaminar
position (Relaix et al., 2005). Intriguingly, Pax3/7+MRF progen-
itors rapidly upregulate Myf5 and downregulate Pax3 expression
upon arrival at the nascent muscle groups (Kassar-Duchossoy
et al., 2005). Lineage tracing suggests that Pax3+ cells contribute
to embryonic myoblasts and the endothelial lineage whereas
Pax7+ cells contribute to fetal myoblasts supporting the notion
that these represent distinct myogenic lineages (Hutcheson
et al., 2009). Thus, satellite stem cells (Pax7+/Myf5) in adult
muscle may be a lineage continuum of the embryonic Pax3/
7+MRF progenitors (Kuang et al., 2007).DevelopmPax3 and Pax7 have overlapping but largely nonredundant
roles in the myogenic developmental program. An outstanding
question is which target genes mediate the distinct function of
Pax7 in adult satellite cells? Given the 86% sequence similarity
between Pax3 and Pax7 proteins, an even intriguing question
is which attributes of Pax7 specify those distinct biological
functions. Here, we tackled these key questions using genomic
approaches. Our experiments have provided a mechanistic
understanding of transcription activities of Pax7 and Pax3 in
adult satellite cells.
RESULTS
Genome-wideBinding of Pax3andPax7 inAdult Skeletal
Muscle
To facilitate comparative analysis between Pax3 and Pax7, we
produced stable cell lines with similar expression level of
Pax3-TAP and Pax7-TAP (Figure 1A). Importantly, this approach
facilitated our analysis as endogenous Pax7 was completely
repressed by proviral expression of either Pax3-TAP or Pax7-
TAP, and thus not involved in the dimerization of Pax complexes.
We estimated proviral expression levels against wild-typeental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevier Inc. 1209
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Figure 2. Differential Binding of Pax7 and Pax3 to Homeobox and Paired Motifs
(A and B) Pax7 and Pax3 binding sites obtained fromChTAP-seq are enriched for homeobox (hbox) and paired (prd) motifs. Consensus sequence of hbox and prd
motif obtained from MEME (Bailey et al., 2009) analysis of the top 500 Pax3/Pax7 peaks, ranked based on MACS (Zhang et al., 2008) scores. MEME search was
restricted to a 50 bp window around peak summit. See Figure S2 for a description of ChTAP and validation of a subset of targets.
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Distinct Function of Pax7 in Adult Myogenesismyoblasts by fluorescent activated cell sorting coupled with
quantitative western blot analysis. Proviral Pax7 was expressed
at 6 3 105 molecules per cell compared to 2.75 3 104 endoge-
nous Pax7 molecules per cell (Figure S1 available online).
The use of ChTAP allowed us to perform ChIP using two
sequential immunoprecipitation steps under identical conditions
by using same affinity reagents in experiments and control
reactions, therefore reducing the likelihood of false positives
(Figure S2; Supplemental Experimental Procedures). This
approach allowed us to conduct a direct comparison between
Pax3 and Pax7.
Ultra high-throughput sequencing of ChTAP fragments on
a GAIIx sequencer (Illumina) (see Supplemental Experimental
Procedures) yielded 11.4 million uniquely mapped reads for
Pax7, 12.4 million reads for Pax3, and 8.5 million reads for the
control sample (The ELAND output of Pax3 and Pax7 ChIP-seq
data are available in GEO as the series GSE25064 containing
TAP-tagged Pax7, TAP-tagged Pax3, and control samples;
GSM615619, GSM615620, and GSM615621, respectively). To
identify genome-wide Pax3 and Pax7 binding sites, reads from
Pax3 or Pax7 together with the corresponding control reads
were analyzed using Model-based Analysis for ChIP-Seq
(MACS v 1.3) (Zhang et al., 2008). Binding sites (peaks) were
identified by comparing Pax3 and Pax7 read densities against
the TAP background (control).
ChIP-PCR established the veracity of binding site identifica-
tion in 100% of the sites tested (Figure S2).
We have previously shown that the presence of C-terminal
TAP tag does not interfere with Pax7 function (McKinnell et al.,
2008). Similarly, we found that the C-terminal TAP tagged Pax3
fully retains its function (Figure S3).
The vast majority of Pax3 and Pax7 binding sites were located
within intergenic or intronic regions away from the transcription
start sites (TSS) (Figure 1B; Figure S4). Few binding sites were
observed within 50 or 30 untranslated regions. The majority of
Pax3 binding sites were found to overlap Pax7 binding sites
(Figure 1C). Surprisingly, while more than 52,683 genomic loci
were enriched for Pax7 binding only 4,648 sites were similarly
enriched for Pax3 (Figure 1C). This striking difference in binding
was observed despite each transcription factor having a com-
parable numbers of reads and equivalent expression levels
(Figures 1A and 1D).
Although the majority of Pax3 binding sites overlap with Pax7
binding sites, a significant 1,267 binding sites were uniquely
occupied by Pax3 and not by Pax7 (Figure 1C). Analysis revealed
that Pax3/Pax7 common peaks set had the highest quality score
compared to the other peak sets (Figure 1D). Analysis of read(C) Pax7 peaks were ranked based on MACS scores. Peaks were binned into gro
prd, hbox or both prd/hbox was determined by FIMO (Grant et al., 2011) using th
peak summit.
(D) Similar analysis of Pax7 unique peaks also showed that hbox motif is highly e
(E and F) The relative distribution of prd and hbox motifs in Pax3 and Pax3 unique
(G) Box plots visualizing fraction of peaks containing hbox motif for Pax3 and P
100-peak groups. The fraction of peaks within each 100-peak group containing t
Data were transformed into percentiles. Wilcoxon rank-sum test shows that the m
compared to Pax3. Dashed red line represents the mean; solid black line inside t
the 95th percentiles, respectively.
(H) Similar analysis as in (G) showing that the fraction of Pax3 peaks containing
See also Figure S2.
Developmdistribution within the common peak set showed a modest
correlation between Pax3 and Pax7. However, these peaks
were more enriched for Pax7 reads than Pax3 (Figure 1E). Taken
together, these finding suggest that Pax7 has more extensive
genome coverage in adult myoblasts than Pax3. However,
Pax3 binds a substantial set of targets not bound by Pax7.
Thus, these data argue that Pax3 and Pax7 binding dynamics
are markedly different in primary adult myoblasts.
Pax3 and Pax7 Bind to Identical DNA Motifs
To determine the consensus-bindingmotif of Pax3 and Pax7, we
ran MEME (Bailey et al., 2009) on the highest scoring Pax3 and
Pax7 unique peaks (Figures 1C and 1D), restricting our search
to the 50 bp region around the peak summit. Peaks that spanned
more than 800 bp were excluded from all downstream analysis
as these were thought less likely to be the result of a single
binding site. The MEME search of Pax7 peaks found the
homeobox-binding (hbox) motif (Figure 2A) in 409 out of the
top 500 peaks. The search of Pax3 peaks identified a paired
(prd) motif (Figure 2B) in 131 out of 499 peaks.
We then used the position weight matrix (PWM) of thesemotifs
to search a 200 bp region surrounding the summit of all Pax3,
Pax7, Pax3 unique and Pax7 unique peaks using FIMO (Grant
et al., 2011). Globally, we found that both Pax7 and Pax3 peaks
were highly enriched for hbox motifs (Figures 2C–2E). On
average more than 60% of all Pax7 and 30% of all Pax3 peaks
contained hbox motif (Figures 2C–2E). Interestingly, both Pax3
peaks and Pax3 unique peaks were more enriched for the prd
motif than the Pax7 peaks (Figures 2D and 2F).
To test the statistical significance for differential enrichment of
Pax3 and Pax7 peaks for prd versus hbox motifs, we ranked
Pax3 and Pax7 peaks into percentile and determined mean
number of hbox and prd motifs within each group. The Wilcoxon
rank-sum test showed that the differential enrichment of Pax3
and Pax7 for prd and hbox motif, respectively, is statistically
significant (p value < 0.001) (Figures 2G and 2H). This finding
suggests that while both Pax3 and Pax7 recognize the same
DNA motif, there is a differential preference for prd versus
hbox between the two transcription factors.
To test the biological significance of Pax3 and Pax7 bias
toward prd and hbox motifs, we performed electromobility shift
assay (EMSA) using short oligonucleotides derived from
a common Pax3/Pax7 binding site (Myf5 ECR111, Supplemental
Experimental Procedures and described below) that contains
both hbox and prd motifs (Figure 3). EMSA confirmed the
differential binding bias for hbox versus paired-domain motifs
between Pax7 and Pax3 respectively (Figures 3A and 3B).ups of 100. A single bar represents each bin. The fraction of peaks containing
e PWM obtained from MEME suite above from the scan of 200 bp around the
nriched in this peak subset.
peaks. Pax3 peaks have a higher proportion of prd to hbox compared to Pax7.
ax7 total peaks. Peaks were ranked based on MACS scores and binned into
he hbox motif was calculated based on the FIMO analysis as describe earlier.
ean fraction peaks containing hbox motif is significantly higher in Pax7 data set
he box represent median. Lower and upper solid circles represent the 5th and
prd motif is significantly higher than those of Pax7.
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Figure 3. Pax7 Dominantly Binds Homeo-
box Motif
(A and B) EMSA showing Pax3 and Pax7 binding to
hbox and prdmotif taken fromMyf5 ECR111 locus.
Pax7 shows higher affinity to hboxmotif than Pax3
(A). On the other hand both Pax3 and Pax7 show
equal affinity for prd motif. Also see Figure S3 and
Supplemental Experimental Procedures.
(C) Three copies of ECR111 were directionally
cloned into a pGL4.10 reporter vector driven by
a Myf5 minimal promoter (Summerbell et al.,
2000). 10T1/2 fibroblasts were cotransfected with
Pax3- and Pax7-VP16 fusion constructs consist-
ing of Pax3 or Pax7 fused in-frame with a VP16
transcriptional activation domain (Lin et al., 1991)
at the C terminus. Expression of luciferase was
measured and normalized to renilla expression.
Relative luciferase activity was normalized against
a control (VP16) reporter construct. Both Pax3-
and Pax7-VP16 drove luciferase expression to
high levels, demonstrating that ECR111 has
enhancer activity and suggests that a combination
of paired and homeodomain motifs produce
synergistic effects on enhancer activity.
(D) Luciferase reporter assay showing transcrip-
tional output of Pax3- and Pax7-VP16 on prd and
hbox motifs. Three copies of the prd or hbox of
ECR111 were concatamerized and cloned into
pGL4.10 luciferase construct as described. Pax7-
VP16 produced a significant increase in luciferase
expression relative to controls and Pax3-VP16.
Error bars represent SD.
See also Figure S3.
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Distinct Function of Pax7 in Adult MyogenesisPax3 weakly shifted the hbox probe, whereas equivalent
amounts of Pax7 protein resulted in a robust shift (Figure 3A).
Two species of shifted probe were identified, likely representing
monomer and dimer binding consistent with a previous report
suggesting that homeobox repeats facilitate dimerization
(Birrane et al., 2009).
To further document the differential affinities of Pax3 versus
Pax7 for paired-and homeodomain motifs, we performed lucif-
erase reporter assays on a set of reporter plasmids containing
different permutations of the Myf5 111 kb binding site
(ECR111). Reporter constructs were engineered that contained
either three copies of the paired-domain sequence (prd), three
copies of the homeodomain sequence (hbox), or three copies
of the full binding site (prd + hbox) (Supplemental Experimental
Procedures).
Reporter plasmids were cotransfected with plasmids ex-
pressing Pax3-VP16, Pax7-VP16, or empty vector, into 10T1/2
fibroblasts. Both Pax3- and Pax7-VP16 were able to induce
the expression of luciferase reporter gene when prd and hbox
were juxtaposed (Figure 3C). However only Pax7 significantly
induced the expression of reporter gene from the hbox motif
alone (Figure 3D), and both Pax3- and Pax7-VP16 were weak
inducers from prd motif alone (Figure 3D). Pax3- and Pax7-
VP16 showed comparable effect on induction of reporter gene
expression from the juxtaposed prd and hbox motifs (Figure 3C).
Notably, the presence of prd and hbox domain has a synergistic
effect on gene expression.
The unique ability of Pax7 to induce expression from the hbox
motif in addition to prd/hbox is consistent with the enrichment of1212 Developmental Cell 22, 1208–1220, June 12, 2012 ª2012 ElsevPax7 binding to hbox motifs in the genome-wide binding data
(Figure 2). Therefore, high affinity of Pax7 for hbox motif (Fig-
ure 3A) and the higher fraction of Pax7 peaks containing thismotif
(Figures 2C and 2D) is consistent with the notion that Pax7
binding to hbox motifs has a biologically important role in adult
myogenesis. Conversely, lower affinity of Pax3 for the hboxmotif
(Figure 3A) combined with the lower fraction of Pax3 peaks con-
taining this motif (Figures 2E–2H) suggests that the two Pax
proteins have markedly different DNA-binding dynamics.
Pax7 Acts over Long Ranges to Regulate the Adult
Myogenic Program
Investigation of Pax3 and Pax7 genome-wide binding data
suggests that they both can regulate their targets from a wide
range of distances to the TSS (Figure 1B; Figure S4). To investi-
gate the functional significance of genes associated with Pax3
and Pax7 peaks, we used Genomic Regions Enrichment of
Annotation Tools (GREAT) (McLean et al., 2010) to perform
association analysis. We used the basal regulatory domain of
between 5 kb and + 1 kb of the TSS and extending to 500 kb
in both upstream and down stream directions to obtain gene
ontologies that were significantly associated with Pax3 and
Pax7 binding sites.
We observed significant enrichment of Gene Ontology terms
such as regulation of myoblast proliferation, hepatocyte growth
factor receptor signaling, regulation of mitosis, regulation of
glucagon secretion and apical junction assembly among other,
associatedwith Pax7 or Pax3 peaks (Tables S1 andS2). Interest-
ingly, peaks that were uniquely present in the Pax3 and absentier Inc.
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A Figure 4. Pax3 and Pax7 Binding Sites Are
Associated with Their Target Genes
(A) Gene expression values from Pax3 over-
expressing cells were ranked based on SAM fold
change and binned into 20 groups. See Figure S4
for significant target genes. Peaks located
between 30 and + 5 kb from the TSS were as-
signed to those genes. The significance of peak to
gene association for each bin was analyzed by
one-sided binomial test against the global peak to
gene fraction (red shows binomial test p values,
blue shows peak associated gene fractions for
each bin). The lines are LOESS fits of the data to
help visualize the trend. Lower graph shows
ranked gene expression values.
(B) Similar analysis as above for the association of
peaks to genes for Pax7 data set. Input gene
expression is from Pax7 overexpressing primary
myoblasts and genome-wide Pax7 binding sites.
The association analysis was restricted to binding
sites within 30 and + 5 kb of the TSS, excluding
binding sites that were further away from TSS.
See Figure S4 for the distribution of Pax3 and Pax7
binding sites with respect to TSS.
See also Tables S3, S4, S5, and S6.
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Distinct Function of Pax7 in Adult Myogenesisfrom the Pax7 data set showed significant enrichment for
ontology terms such as skeletal muscle morphogenesis, neural
tube formation and epithelial tube formation among others
(data not shown). This finding suggests that Pax3 peaks that
are not present in the Pax7 data set may represent a set of
Pax3 targets involved in embryonic myogenesis.
To assess the relationship between genome-wide binding
data and gene expression, we performed microarray analysis
on Pax3- and Pax7-CTAP overexpressing skeletal myoblasts.
We used significance analysis of microarray (SAM) with a raw
p value < 0.01 and a fold change R2.0 (positive or negative)
to derive the list of genes that were differentially regulated.
Consistent with our observation on genome-wide binding data,
Pax7 overexpression resulted in differential regulation of a larger
set of genes than Pax3 overexpression (Figure S4).Developmental Cell 22, 1208–122A set of 840 genes was significantly
regulated by both Pax7 and Pax3, while
128 genes were significantly regulated
byPax3only, anda larger set of 439genes
was regulated by Pax7 only (Figure S4).
Many genes associated with growth and
proliferation, such as Fgfr2, Egfr, BMP4,
etc., were significantly upregulated by
both Pax3 and Pax7 (Table S3). Differenti-
ation-specific genes, such as Myh1,
Myh3, Myh8, Mef2c, Myog, Ttn, etc.,
were significantly repressed by both
Pax3 and Pax7 (Table S3).
Gene ontology analysis showed that
both Pax3 and Pax7 regulated genes
are involved in cell growth, proliferation,
signaling, adhesion, etc. (Tables S4 and
S5). However, Pax7 induced the expres-
sion of many genes involved in growthand proliferation of muscle cells and repressed a large set of
genes involved in muscle cell differentiation. The latter gene
sets are not significantly regulated by Pax3 (Table S6).
Based on a statistical analysis of peak association with signif-
icantly regulated gene expression (data not shown), we chose
a 35 kb window (30 kb to +5 kb) around the TSS. To determine
the significance of association between Pax3 and Pax7 binding
and expression of target genes, we grouped genes into 20 bins
ranked by their expression fold change. A binomial test on the
number of genes with associated peaks in each bin versus the
proportion of all geneswith associated peaks showed that genes
that are up- or downregulated in Pax7 overexpressing cells and
genes that are upregulated in Pax3 overexpressing cells have
significantly more associated peaks than would be expected at
random or nonregulated genes (Figure 4).0, June 12, 2012 ª2012 Elsevier Inc. 1213
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Figure 5. Myf5 –111 kb Is a Common Evolutionarily Conserved Target of Pax3/7
(A) Schematic of the regulatory regions for Myf5 depicting the multitude of enhancer elements that direct Myf5 expression at different times and at different
anatomical locations.
(B) Pax3 binding sites are found at 129, 111, and 57.5 kb, as determined by ChIP-Seq analysis primary myoblasts stably expressing Pax3. The regulatory
element at 57.5 kb directsMyf5 expression in somites, trunk, and limb muscles (Bajard et al., 2006). Pax7 binding sites are also present on Myf5/6 regulatory
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Distinct Function of Pax7 in Adult MyogenesisWe performed similar analysis using Gene Set Enrichment
Analysis (GSEA) (Broad Institute, v 2.07) (Subramanian et al.,
2005) and observed comparable results (data not shown). Taken
together, these analyses suggest that overall transcriptional
activity of Pax3 and Pax7 can be predicted from their binding
patterns. Moreover, despite a significant amount of functional
overlap between the two Pax genes in skeletal muscle cells
Pax7 plays a more dominant role in adult skeletal myogenesis.
Distinct Roles for Pax3 and Pax7 in Adult Myogenesis
Pax3 has been documented to target several enhancers that are
activated during embryonic myogenesis. We examined Pax7
and Pax3 binding to these regions to elucidate whether the adult
myogenic program is simply a continuation of the embryonic
myogenic program. Surprisingly, we did not find extensive
Pax3 binding to known targets. For example, no Pax3 peak
was identified at the paired motif-containing +22 kb enhancer
downstream from Fgfr4, which is bound by Pax3 during embry-
onic limb development (Bajard et al., 2006; Lagha et al., 2008).
However, this element is strongly bound by Pax7 (Figure S5).
Dmrt2, a known Pax3 target is involved in somite maturation
and is regulated by Pax3 via a conserved element located 18
kb upstream of the TSS (Sato et al., 2010). However, our data
show that in adult myoblasts this element is strongly bound by
Pax7 but not Pax3 (Figure S5). Another Pax3-regulated gene,
Spry1 (Lagha et al., 2008) has a Pax7 binding site but no Pax3
binding at a conserved element located +12 kb downstream of
the TSS (Figure S5).
Binding sites uniquely recognized by Pax7 were also found
near key myogenic genes. For example, two prominent Pax7
binding sites were found in conserved intergenic regions
upstream of MyoD. These sites were also not bound by Pax3
(Figure S5). In other instances we observed that Pax7 binding
sites were frequently adjacent to Pax3 target genes. For
example, prominent binding sites were observed in the promoter
of Lbx1, and within and downstream of Itm2a (Figure S5).
Consistent with previous findings, common Pax3/7 binding
sites were observed within or near known target genes, including
Myf5 (Bajard et al., 2006), C-met (Epstein et al., 1996), and
Cdh11 (McKinnell et al., 2008) (Figure S5). Other Pax3/7 sites
were observed adjacent to genes linked to muscle-related
processes like myogenic inhibition (such as Mdfic; Ma et al.,
2003) andmyogenic signaling (Stat1; Sun et al., 2007) (Figure S5;
data not shown). Although Myf5 showed Pax3/7 binding at its
57 kb limb enhancer (Bajard et al., 2006), we noted a larger
peak located at 111 kb from the Myf5 TSS in both Pax3 and
Pax7 data sets (Figure 5B). These observations suggest that in
adult cells Pax7 binds strongly to many sites occupied by
Pax3 in the embryo. Taken together, these data support theregion and are found within the satellite cell region as well as regions directing e
however, the peak at 111 kb is the most enriched. Also see Figure S5 for bindi
(C) Chromatogram ofMyf5 57 kb probe incubated with Pax3 or Pax7 (red) or B
between Pax3 and Pax7, centered on a paired domain motif.
(D) Chromatogram ofMyf5 111 kb probe. Identical protected regions (black bar
containing a putative paired domain and a separate homeodomain motif (Wilson
implies that multiple Pax7 molecules may simultaneously bind.
See also Figure S5.
Developmnotion that adult and embryonic programs represent discrete
myogenic programs.
Our experiments reveal that Pax7 plays an extensive role in
adult myogenesis by activating multiple programs to promote
myoblast growth and inhibit differentiation. Pax7 also activates
components of multiple signaling pathways that have been
implicated in adult myogenesis.
Pax7 Activates Myf5 in Satellite Cells via ECR111
Element
Myf5 is a direct Pax3/7 target gene that is transcriptionally
poised in quiescent satellite stem cells. Myf5 is induced through
asymmetric satellite stem cell division and is rapidly upregulated
during activation of satellite myogenic cells (Kuang et al., 2007;
Le Grand et al., 2009; McKinnell et al., 2008). Pax7 is a potent
positive regulator of Myf5 in cultured myogenic cells. BAC trans-
genes carrying 195 kb upstream of the Myf5 transcriptional start
site are sufficient to recapitulate the expression pattern of Myf5
and Myf6 in the embryo (Carvajal et al., 2001), and in the adult
(Zammit et al., 2004). The 140 to 88 kb interval is necessary
for the expression of Myf5 in quiescent satellite cells, while the
element directing Myf5 expression in proliferating myogenic
cells is located between 59 and +40.6 kb (Zammit et al.,
2004) (summarized in Figure 5).
Analysis of Pax3 and Pax7 ChIP-Seq data identified a
number of binding sites across the Myf5 regulatory region
(Figures 5A–5C). Both Pax3 and Pax7 bound sites are located
at conserved loci at 57.5, 111, and 129 kb (relative to the
Myf5 TSS). Within the 52 kb upstream interval (140 to 88
kb), harboring the satellite cell enhancer we identified four evolu-
tionary conserved regions (ECRs) (Figure 5B), among them
ECR111 (Ribas et al., 2011) is conserved in all vertebrates. We
confirmed the precise binding of Pax3/7 to the57 kb enhancer
(Figure 5C) and the ECR111 by DNaseI foot printing (Figure 5D)
and Supplemental Experimental Procedures.
We examined Myf5 expression in vivo using a Myf5-nLacZ
BAC carrying 195 kb of upstream sequence (Figures 6A–6H;
Figure S6; Supplemental Experimental Procedures). Transgenic
mice harboring a deletion of the ECR111 sequence from the BAC
transgene (Ribas et al., 2011) abolished the expression of
Myf5-nLacZ from adult quiescent satellite cells, but not muscle
spindles (Figure 6; Figure S6). These results indicate that
ECR111 is required for the expression of Myf5 in satellite cells
but is not required for its expression in muscle spindles. Interest-
ingly, activated satellite cell derivedmyogenic cells from cultured
EDL single fibers expressed Myf5-nLacZ in the absence of
ECR111 (data not shown). Therefore, we conclude that the
ECR111 is a bona fide Pax7-dependent enhancer, which is
required for Myf5 expression in adult quiescent satellite cells.xpression in limbs and muscle spindles. Pax7 commonly binds all Pax3 sites;
ng of Pax3 and Pax7 of a representative set of known targets.
SA (blue) and digested with DNaseI. The 29-bp footprint (black bar) is identical
) were observed in the presence of Pax3 or Pax7. The footprint spans a region
et al., 1993). The distance between each motif and the length of the footprint
ental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevier Inc. 1215
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Figure 6. ECR111 Is an Enhancer Element
Required for Myf5 Expression in Quiescent
Satellite Cells
Cryosections of adult Soleus (A, B, E, and F) and
EDL (C, D, G, and H) muscles from B195APZWT.
(A–D) and B195APZD111 (E–H) transgenic lines
show that in the absence of the ECR111 enhancer
harboring the Pax7 binding site, expression in the
satellite cells is abolished. Note that in transgenic
animals carrying the deleted BAC construct
expression in muscle spindle cells, under the
transcriptional control of a separate enhancer, is
not affected.
Red boxes in (A), (C), (E), and (G) indicate the
zoomed regions shown in (B), (D), (F), and (H),
respectively. Additional satellite and muscle
spindle cells not included within the close-up
figures are also indicated (black and white arrows,
respectively).
See Figure S6.
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In the hierarchy of the myogenic transcriptional network, Pax3
and Pax7 lie upstream of the basic helix-loop-helix (bHLH) tran-
scription factors Myf5 and MyoD. Together, these transcription
factors regulate satellite cell commitment to the myogenic
lineage and self-renewal through a spatial-temporal network
regulated by various signaling pathways. Deciphering the
precise underlying molecular mechanisms that regulate this
network is fundamentally important in understanding muscle
development and diseases. Pax3/7 expressing cells that origi-
nate from somites give rise to the satellite cells of postnatal
muscle (Buckingham and Relaix, 2007).
Gene replacement studies have demonstrated temporal and
functional overlap of Pax3 and Pax7 in both embryonic and
adult tissue. However, both factors have critical nonredundant
roles in embryonic and adult muscle development. Pax7 can
competently replace Pax3 in neural crest cells, dorsal neural
tube, and trunk muscles, but cannot compensate for Pax3 func-
tion in the delamination and migration of limb muscle progenitor
cells (Relaix et al., 2004). Conversely, Pax7 alone is essential for
satellite cells up to a critical postnatal period (Kuang et al., 2007;
Lepper et al., 2009; Oustanina et al., 2004; Relaix et al., 2006;
Seale et al., 2000).
To mechanistically investigate the functional differences
between Pax3 and Pax7 in skeletal myogenesis, we combined
global gene expression profiling with genome-wide binding site
analysis of these two closely related transcription factors in
satellite cell-derived myoblasts. Our analyses of genome-wide
binding site and gene expression data point to a more dominant
role for Pax7 in adult skeletal muscle cells. Surprisingly, we found
that Pax7 binds to many more sites (Figure 1) than the number of
genes it regulates (Figure S4). This discrepancy between binding
and expression data can be partially explained by the occur-
rence of multiple binding sites on the same gene. For example,
analysis of Pax7-regulated genes revealed that on average there
were three binding sites within 35 kb of the TSS of these genes.
However, a large fraction of the remaining binding sites were
dispersed throughout the genome. The functional relevance of
these binding sites is unknown.1216 Developmental Cell 22, 1208–1220, June 12, 2012 ª2012 ElsevAnalysis of peak to gene association revealed that both Pax3
and Pax7 regulated genes are significantly enriched for Pax3
and Pax7 peaks compared to nonregulated genes (Figure 4).
Association studies between binding sites and nearby genes
using GREAT (McLean et al., 2010) revealed that Pax7 binding
sites are highly associated with genes involved in growth,
myoblast proliferation and muscle cell differentiation (Table
S1). This finding is consistent with the expression data in which
Pax7 upregulates a significant set of genes that are involved in
cellular growth, adhesion, and signaling pathways (Table S3).
On the other hand, Pax7 also represses numerous genes that
are involved in terminal differentiation (Table S3). Global analysis
of peak to gene association showed that both up- and downre-
gulated genes are significantly enriched for Pax7 binding sites
(Figure 4). This raises the question of whether Pax7 can act as
a repressor. Previous studies have indicated that Pax7 appears
exclusively associated with active chromatin (McKinnell et al.,
2008). Therefore, it is interesting to speculate that Pax7 binding
to differentiation-specific genes functions to maintain these
genes transcriptionally poised during progenitor proliferation.
Strikingly, our data show that despite recognizing the same
binding motifs, Pax3 and Pax7 have significant differential
affinities for paired versus hbox motifs (Figures 2 and 3). Pax7
strongly binds to hbox motifs (Figure 3A) and potently induces
transcription of a reporter gene from this motif (Figure 3D), while
Pax3 has low affinity for hbox motifs (Figure 3A) and a corre-
spondingly lower transcriptional output on the same motif
relative to Pax7 (Figure 3D). On the other hand, when prd and
hbox are juxtaposed, both Pax3 and Pax7 have a similar effect
on the transcription of a reporter gene (Figure 3C). This finding
is consistent with the distribution of prd and hbox motifs in the
full set of Pax3 and Pax7 binding sites (Figure 2). The observed
differences between Pax3 and Pax7 affinities for prd and hbox
motifs is surprising given the degree of protein sequence simi-
larity between the two transcription factors in their paired and
homeodomains.
Our data demonstrate that these intrinsic differences in DNA
binding between Pax3 and Pax7 drive differential activation
from promoters containing specific paired and hbox configura-
tions. Work in Drosophila suggests that Pax proteins recognizeier Inc.
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domains. Synergistic binding of paired- and homeodomains is
required for the expression of even-skipped (Jun and Desplan,
1996); similarly, we observed synergistic activation of the
ECR111 element in Myf5 when both domains were juxtaposed
(Figure 3C). Our data suggest that the distinguishing feature
of Pax7 and Pax3 in adult skeletal muscles is that Pax7 can acti-
vate target gene expression from combined prd/hbox or hbox
motifs alone, while Pax3 is ineffective in inducing transcription
from only hbox motifs. We hypothesize that the observed tran-
scriptional dominance of Pax7 over Pax3 is largely due to the
greater affinity of Pax7 for hbox elements relative to Pax3.
Additional mechanisms may differentially influence the DNA
binding affinity of Pax3 and Pax7. We observed several cases
where embryonic Pax3 binding sites are poorly associated with
Pax3 in adult cells, but robustly bound by Pax7 as indicated
previously. DNA binding by Pax3 may require the presence of
specific coactivators or posttranslational modifications. It has
been suggested that Pax3 activity is dependent on phosphoryla-
tion, as Pax3 transcriptional activity is blocked by kinase inhibi-
tion (Amstutz et al., 2008; Miller et al., 2008). Pax3 is phosphor-
ylated at Ser205, proximal to the octapeptide domain. Mutation
of this site not only abolishes phosphorylation, but also disrupts
dimerization of Pax3 proteins. Homeodomain-binding motifs are
thought to facilitate dimerization through inverted repeats of
‘‘TAAT’’ and we see a substantial difference in affinity between
Pax3 and Pax7 binding to hbox motifs. Pax3 has been shown
to cooperate with Sox10 to synergistically activate target gene
expression (Mascarenhas et al., 2010).
Epigeneticmodificationsmay also play a role in directing avail-
ability of binding sites to Pax3 or Pax7. For example, RARg/
RXRa heterodimers competently bind and induce retinoic acid
response elements (RAREs) regulating Hoxa1 and Cyp26a1 in
F9 teratocarcinoma stem cells, but not in Balb/c 3T3 fibroblasts
(Kashyap and Gudas, 2010). This is attributed to retinoic acid-
induced reduction of polycomb protein Suz12 and associated
H3K27 trimethylation of Hoxa1 and Cyp26a1 RAREs. To what
extent each of these factors contribute to the overall transcrip-
tional network of Pax3 and Pax7 during myogenesis remains
largely unknown.
Our experiments indicate that in adult myoblasts, Pax7 regu-
lates many more genes than Pax3. We propose that many
Pax7-only binding sites are regulatory elements for genes
essential to the normal function of adult myogenic cells while
their low affinity to Pax3 explains the inability of Pax3 to compen-
sate for Pax7 in Pax7/ muscles such as in the diaphragm.
Ultimately, the distinct characteristics of Pax3 and Pax7 binding
provide a framework for understanding the differences in
transcriptional network organization between embryonic and
adult myogenesis. Both factors may be sufficient to initiate
myogenic programs, but different developmental contexts may
utilize alternative networks to fulfill other essential roles.
Consistent with the dominant role of Pax7 DNA binding, our
gene expression data show a panel of 439 genes that are sig-
nificantly regulated by Pax7 but not Pax3. These genes are
involved in diverse biological functions such as growth,
signaling, cell adhesion, and muscle cell differentiation (Table
S6). For example, Pax7’s ability to induce Rspo1 and BMP4
among others (Table S3) suggests a mechanism by whichDevelopmPax7 functions in the expansion of satellite cell population.
Rspo1, a known Wnt/ b-catenin activator is known to regulate
Myf5 expression in myoblasts (Han et al., 2011). We observed
a Pax7 peak located at +12 kb of the TSS of Rspo1. BMP4 is
characterized in its ability to block the differentiation ofmyogenic
cells (Dahlqvist et al., 2003). We observed a Pax7 peak on
a highly conserved element at 28.7 kb of BMP4. Additionally
Pax7 overexpression resulted in the repression of many muscle
differentiation genes (Tables S3 and S6).
Myf5 is activated by Pax3 or Pax7 in both embryonic and skel-
etal muscle, and it has been shown that adult Myf5 enhancers
operate independently of one another (Carvajal et al., 2008;
Zammit et al., 2004). Embryonic regulation of Myf5 can occur
through the 57.5 kb enhancer, whereas deletions within
Myf5-LacZ BACs show the 140 to 88 kb region is critical for
the expression of Myf5 in quiescent satellite cells. Our data
confirm that ECR111 is a Pax7-dependent enhancer that is
evolutionarily conserved and directs Myf5 expression in quies-
cent satellite cells (Figure 6; Figure S6). The continued expres-
sion of Myf5-nLacZ in the ECR111 mutant in muscle spindles
reinforces the idea that separate genetic elements control
Myf5 expression between quiescent satellite cells and muscle
spindles.
We have mapped Pax3 and Pax7 binding sites and identified
common and discrete target genes. Our experiments have
demonstrated that the disparate affinities of Pax3 and Pax7 for
paired- versus homeomotif provide a mechanistic explanation
for the distinct role played by Pax7 in adult myogenesis. Impor-
tantly, the ability of Pax7 to specify myogenic identity while stim-
ulating growth and inhibiting differentiation points to a central
role in the regulation of myogenic progression of the adult
satellite cell lineage. This work has facilitated the identification
of gene interactions and represents an important step toward
comprehensively defining the myogenic regulatory transcrip-
tional network. Understanding the myogenic transcriptional
network will have important implications for elucidating the
molecular control of the myogenic developmental program,
and for the genetic modulation of stem cells for use in the
amelioration of muscle disease.EXPERIMENTAL PROCEDURES
Chromatin Tandem Affinity Purification
Subconfluent myoblasts stably expressing a C terminus TAP-tagged Pax3
or Pax7 were crosslinked with 1% formaldehyde in 1 3 PBS. Cells were
harvested by scraping and the cell pellet was dissolved in ChIP lysis buffer
(Supplemental Experimental Procedures). Chromatin was purified using two
sequential immunoprecipitation steps. The first immunoprecipitation was
done using anti-33FLAG antibody conjugated to agarose beads (Sigma
Aldrich) using 20 mg of cell lysate as input for 2 hr at 4C. Beads containing
antigen/antibody complex were washed three times with 10 mM Tris-HCl
(pH 8.0); 100 mM NaCl; 0.1% Triton X-100 containing protease inhibitors.
Protein complex was eluted fromM2-conjugated agarose beads using proteo-
lytic cleavage with Tobacco Etch Virus (TEV) protease (Invitrogen) together
with competition with 33FLAG peptide (Sigma Aldrich) at 4C overnight.
Two additional rounds of elution with 33FLAG peptides were done using
200 mg/ml of 33FLAG peptide in TBS (50 mM Tris-HCl [pH 7.4]; 150 mM
NaCl). The eluted product was used as input for the second affinity pull
down using His-Select nickel beads (Sigma-Aldrich) for three hours at 4C
following manufacture’s recommendations. Beads were washed three
times with wash buffer (20 mM Tris-HCl [pH 7.4]; 150 mM NaCl; 5 mMental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevier Inc. 1217
Developmental Cell
Distinct Function of Pax7 in Adult Myogenesisimidazole). Final DNA/protein complex was eluted by 400 mM imidazole at
room temperature. Reverse crosslinking and phenol/chloroform extraction of
chromatin were done as described previously (Gillespie et al., 2009). ChIP
with Pax7-FLAG, EGFP, and puro cell lines were fixed in 1% formaldehyde
solution and immunoprecipitated with M2-agarose (Sigma-Aldrich). Washing
and DNA elution were performed according to the ChIP Assay Kit (Upstate).
Enrichment of particular loci within ChIP DNA pools was determined by quan-
titative real-time PCR.
Gene Expression Analysis
Total RNA was isolated from mouse skeletal muscle cells in triplicate by the
RNeasy kit (QIAGEN) and hybridized to Affymetrix Mouse Gene Array ST 1.0
chips and scanned using a GeneChip Scanner 30007G. Raw expression
data were assembled using the Affymetrix GeneChip Command Console
v1.1. SAM was used to derive differentially expressed genes. See Supple-
mental Experimental Procedures for more details.
Peak Calling
Peaks in the mapped Pax7 and Pax3 sequences were identified using MACS
v1.3 (Zhang et al., 2008) using an empty TAP vector ChIP-seq as control. The
following parameters:mfold = 16, bw = 150, p value cutoff of 105 were used in
the peak calling procedure. Peaks greater than 800 bp in width were excluded
from further analysis, based on the size of excised ChIP fragments used for
Solexa sequencing.
Motif Analysis
MEME (Bailey et al., 2009) was used to identify overrepresentedmotifs in Pax3
and Pax7 peak set subsets, restricting the search to 50 bp around the peak
summit. Peaks were filtered by width, MACS score (10 3 log10 [p value])
and repeat content to select regions most likely to reflect specific high-affinity
binding events, and least likely to identify spurious motifs within repetitive
sequences. Peaks greater than 800 bp in length were excluded from the
analysis. See Supplemental Experimental Procedures for more details.
Affymetrix MoGene ST 1.0 Analysis and Annotations
Nine microarrays were used in the analysis. See Supplemental Experimental
Procedures for GEO accession numbers. Transcript cluster identifiers (TCID)
of the Affymetrix MoGene 1.0 ST chipsets were RMA normalization (Irizarry
et al., 2003) using the xps in Bioconductor (Gentleman et al., 2004) R package
with the Affymetrix provided MoGene-1_0-st-v1.r4 chip layout and scheme
files. The RMA normalized results were log2 transformed and analyzed using
the SAM (Tusher et al., 2001) method as implemented in the Bioconductor
siggenes package. The resulting SAM fold changes and raw p values were
integrated into a single table by common TCID and annotated with gene
associations based on probe to gene mappings downloaded from Ensembl
v64 BioMart. TCIDs mapping to zero or more than one gene were excluded
from the analysis. Gene properties were downloaded from Ensembl v64
BioMart and counts of MACS peaks identified peak positions falling within
the chosen gene association window (30 to +5 kb around the TSS) were
provided for each gene.
See Supplemental Experimental Procedures for a more extensive descrip-
tion of procedures and computational methods.
Electromobility Shift Assay
Baculovirus-purified Pax3-FLAG, Pax3-CTAP, or Pax7-FLAG was incubated
with 1.25 ng (ATP g-32P-labeled) DNA probe and nonspecific carrier (poly
dI-dC) in a binding buffer containing 75 mM NaCl, 1 mM EDTA, 1 mM DTT,
10 mM Tris (pH 7.5), 6% glycerol, and 0.25% BSA at room temperature for
20 min (Supplemental Experimental Procedures). Cold probe (253) was
used for competitive binding assays. Supershifts were carried out with the
addition of 1 mg M2- or M5-FLAG antibody (Sigma-Aldrich). Reactions were
analyzed on a 5% nondenaturing polyacrylamide gel (0.5 3 TBE), dried onto
3 mm Whatman paper, and exposed to BioMax MS X-ray film (Kodak).
Luciferase Reporter Assay
ECR111 reporter vectors were constructed as follows. For the paired domain
(PD) and homeodomain (HD) reporters, three copies of 30 bp sequences
covering the prd and hbox motifs were directionally concatamerized and1218 Developmental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevcloned upstream of a minimal Myf5 promoter driving the luc gene of
pGL4.10 (Promega). A 70 bp sequence covering the entire 111 kb region,
including both the prd and hbox regions was also concatamerized and cloned
as above to generate the PDHD reporter. Reporter vectors were cotransfected
with a renilla vector standard and either empty vector (VP16), VP16-Pax7 or
VP16-Pax3 for 24 hr into C3H10T1/2 fibroblasts (also see Supplemental
Experimental Procedures). Luciferase assays were carried out using the
Dual-Reporter LuciferaseAssaySystem (Promega) and analyzed on a Lumistar
Optima (BMG Labtech) fluorescent plate reader.
DNase I Footprinting
Baculoviral purified Pax7 or Pax3 protein or equivalent amount of BSA (NEB)
was equilibrated for 10 min at room temperature in the following buffer:
150 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 8% glycerol, 30 mM Tris-Cl
(pH 8.0), 1 mM DTT along with 1 mg of poly dI-dC (Sigma). DNA probes were
made from ECR57 and ECR111 of theMyf5 locus (Supplemental Experimental
Procedures). One hundred fifty micrograms of each probe was then added
for 20 min at room temperature (also see Supplemental Experimental
Procedures). Probes were then digested with 7.5 3 103 units of DNase I
(Worthington Biochemicals) for 15 min at room temperature. DNA was
purified using MinElute enzymatic reaction cleanup (QIAGEN). Control diges-
tions were performed on an IgH probe. Digested DNA was added to HiDi
formamide (Applied Biosystems) and 0.1 ml GeneScan 500 LIZ size standards
(Applied Biosystems). Mixtures were then heat denatured for 5 min at 95C,
immediately cooled on ice, and analyzed with a 3730 DNA Analyzer (ABI)
running a G5 dye set (see Supplemental Experimental Procedures for more
details).
Statistical Analysis
Gene expression values from Pax3 and Pax7 overexpressing myoblasts
were each ranked based on SAM fold change and binned into 20 groups.
For each bin, we performed a one-tailed binomial test of the proportion of
peak-associated genes in that bin versus all genes. We tested the hypothesis
that the binned genes are more likely to be associated with peaks. The graphs
in Figure 4 show the base 10 logarithms of the binomial test p values.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, six tables, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.devcel.2012.03.014.
ACKNOWLEDGMENTS
We thank Dr. Ricardo Ribas for providing the B195APZ BAC constructs. We
thank Dr. Hang Yin at the Ottawa Hospital Research Institute (OHRI) for his
valuable comments and suggestion on the manuscript. M.A.R. holds the
Canada Research Chair in Molecular Genetics and is an International
Research Scholar of the Howard HughesMedical Institute. This work was sup-
ported by grants from the National Institutes of Health, the Howard Hughes
Medical Institute, the Canadian Institutes of Health Research, and the Canada
Research Chair Program toM.A.R., by EuTRACC, a European Commission 6th
Framework grant to F.G., and by the Institute of Cancer Research, a Medical
Research Council Programme Grant, and MYORES, a European Commission
6th Framework grant to J.J.C. and P.W.J.R.
Received: December 29, 2010
Revised: January 20, 2012
Accepted: March 28, 2012
Published online: May 17, 2012
REFERENCES
Amstutz, R., Wachtel, M., Troxler, H., Kleinert, P., Ebauer, M., Haneke, T.,
Oehler-Ja¨nne, C., Fabbro, D., Niggli, F.K., and Scha¨fer, B.W. (2008).
Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals
novel therapeutic possibilities. Cancer Res. 68, 3767–3776.ier Inc.
Developmental Cell
Distinct Function of Pax7 in Adult MyogenesisBailey, T.L., Boden, M., Buske, F.A., Frith, M., Grant, C.E., Clementi, L., Ren,
J., Li, W.W., and Noble, W.S. (2009). MEME SUITE: tools for motif discovery
and searching. Nucleic Acids Res. 37 (Web Server issue), W202-8.
Bajard, L., Relaix, F., Lagha,M., Rocancourt, D., Daubas, P., andBuckingham,
M.E. (2006). A novel genetic hierarchy functions during hypaxial myogenesis:
Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev.
20, 2450–2464.
Birrane, G., Soni, A., and Ladias, J.A. (2009). Structural basis for DNA recog-
nition by the human PAX3 homeodomain. Biochemistry 48, 1148–1155.
Bober, E., Franz, T., Arnold, H.H., Gruss, P., and Tremblay, P. (1994). Pax-3 is
required for the development of limb muscles: a possible role for the migration
of dermomyotomal muscle progenitor cells. Development 120, 603–612.
Buckingham, M., and Relaix, F. (2007). The role of Pax genes in the develop-
ment of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell
functions. Annu. Rev. Cell Dev. Biol. 23, 645–673.
Carvajal, J.J., Cox, D., Summerbell, D., and Rigby, P.W. (2001). A BAC trans-
genic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that
control activation and maintenance of gene expression during muscle devel-
opment. Development 128, 1857–1868.
Carvajal, J.J., Keith, A., and Rigby, P.W. (2008). Global transcriptional regula-
tion of the locus encoding the skeletal muscle determination genes Mrf4 and
Myf5. Genes Dev. 22, 265–276.
Charge´, S.B., and Rudnicki, M.A. (2004). Cellular and molecular regulation of
muscle regeneration. Physiol. Rev. 84, 209–238.
Dahlqvist, C., Blokzijl, A., Chapman, G., Falk, A., Dannaeus, K., Ibaˆn˜ez, C.F.,
and Lendahl, U. (2003). Functional Notch signaling is required for BMP4-
induced inhibition of myogenic differentiation. Development 130, 6089–6099.
Epstein, J.A., Shapiro, D.N., Cheng, J., Lam, P.Y., andMaas, R.L. (1996). Pax3
modulates expression of the c-Met receptor during limb muscle development.
Proc. Natl. Acad. Sci. USA 93, 4213–4218.
Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S.,
Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004). Bioconductor: open soft-
ware development for computational biology and bioinformatics. Genome
Biol. 5, R80.
Gillespie, M.A., Le Grand, F., Scime`, A., Kuang, S., von Maltzahn, J., Seale, V.,
Cuenda, A., Ranish, J.A., and Rudnicki, M.A. (2009). p38-gamma-dependent
gene silencing restricts entry into the myogenic differentiation program.
J. Cell Biol. 187, 991–1005.
Grant, C.E., Bailey, T.L., and Noble, W.S. (2011). FIMO: scanning for occur-
rences of a given motif. Bioinformatics 27, 1017–1018.
Han, X.H., Jin, Y.R., Seto, M., and Yoon, J.K. (2011). A WNT/beta-catenin
signaling activator, R-spondin, plays positive regulatory roles during skeletal
myogenesis. J. Biol. Chem. 286, 10649–10659.
Hutcheson, D.A., Zhao, J., Merrell, A., Haldar, M., and Kardon, G. (2009).
Embryonic and fetal limb myogenic cells are derived from developmentally
distinct progenitors and have different requirements for beta-catenin. Genes
Dev. 23, 997–1013.
Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J.,
Scherf, U., and Speed, T.P. (2003). Exploration, normalization, and summaries
of high density oligonucleotide array probe level data. Biostatistics 4, 249–264.
Jun, S., and Desplan, C. (1996). Cooperative interactions between paired
domain and homeodomain. Development 122, 2639–2650.
Kashyap, V., and Gudas, L.J. (2010). Epigenetic regulatory mechanisms
distinguish retinoic acid-mediated transcriptional responses in stem cells
and fibroblasts. J. Biol. Chem. 285, 14534–14548.
Kassar-Duchossoy, L., Giacone, E., Gayraud-Morel, B., Jory, A., Gome`s, D.,
and Tajbakhsh, S. (2005). Pax3/Pax7 mark a novel population of primitive
myogenic cells during development. Genes Dev. 19, 1426–1431.
Kuang, S., Charge´, S.B., Seale, P., Huh,M., and Rudnicki, M.A. (2006). Distinct
roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 172,
103–113.
Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M.A. (2007). Asymmetric
self-renewal and commitment of satellite stem cells in muscle. Cell 129,
999–1010.DevelopmLagha, M., Kormish, J.D., Rocancourt, D., Manceau, M., Epstein, J.A., Zaret,
K.S., Relaix, F., and Buckingham, M.E. (2008). Pax3 regulation of FGF
signaling affects the progression of embryonic progenitor cells into the
myogenic program. Genes Dev. 22, 1828–1837.
Le Grand, F., Jones, A.E., Seale, V., Scime`, A., and Rudnicki, M.A. (2009).
Wnt7a activates the planar cell polarity pathway to drive the symmetric expan-
sion of satellite stem cells. Cell Stem Cell 4, 535–547.
Lepper, C., Conway, S.J., and Fan, C.M. (2009). Adult satellite cells and
embryonic muscle progenitors have distinct genetic requirements. Nature
460, 627–631.
Lin, H., Yutzey, K.E., and Konieczny, S.F. (1991). Muscle-specific expression
of the troponin I gene requires interactions between helix-loop-helix muscle
regulatory factors and ubiquitous transcription factors. Mol. Cell. Biol. 11,
267–280.
Ma, X.Y., Wang, H., Ding, B., Zhong, H., Ghosh, S., and Lengyel, P. (2003).
The interferon-inducible p202a protein modulates NF-kappaB activity by in-
hibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers
while enhancing the binding of p50 homodimers. J. Biol. Chem. 278, 23008–
23019.
Mascarenhas, J.B., Littlejohn, E.L., Wolsky, R.J., Young, K.P., Nelson, M.,
Salgia, R., and Lang, D. (2010). PAX3 and SOX10 activate MET receptor
expression in melanoma. Pigment Cell Melanoma Res. 23, 225–237.
McKinnell, I.W., Ishibashi, J., Le Grand, F., Punch, V.G., Addicks, G.C.,
Greenblatt, J.F., Dilworth, F.J., and Rudnicki, M.A. (2008). Pax7 activates
myogenic genes by recruitment of a histone methyltransferase complex.
Nat. Cell Biol. 10, 77–84.
McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B.,
Wenger, A.M., and Bejerano, G. (2010). GREAT improves functional interpre-
tation of cis-regulatory regions. Nat. Biotechnol. 28, 495–501.
Miller, P.J., Dietz, K.N., and Hollenbach, A.D. (2008). Identification of serine
205 as a site of phosphorylation on Pax3 in proliferating but not differentiating
primary myoblasts. Protein Sci. 17, 1979–1986.
Oustanina, S., Hause, G., and Braun, T. (2004). Pax7 directs postnatal renewal
and propagation of myogenic satellite cells but not their specification. EMBO
J. 23, 3430–3439.
Punch, V.G., Jones, A.E., and Rudnicki, M.A. (2009). Transcriptional networks
that regulate muscle stem cell function. Wiley Interdiscip Rev Syst Biol Med 1,
128–140.
Relaix, F., Rocancourt, D., Mansouri, A., and Buckingham, M. (2004).
Divergent functions of murine Pax3 and Pax7 in limb muscle development.
Genes Dev. 18, 1088–1105.
Relaix, F., Rocancourt, D., Mansouri, A., and Buckingham, M. (2005). A Pax3/
Pax7-dependent population of skeletal muscle progenitor cells. Nature 435,
948–953.
Relaix, F., Montarras, D., Zaffran, S., Gayraud-Morel, B., Rocancourt, D.,
Tajbakhsh, S., Mansouri, A., Cumano, A., and Buckingham, M. (2006). Pax3
and Pax7 have distinct and overlapping functions in adult muscle progenitor
cells. J. Cell Biol. 172, 91–102.
Ribas, R., Moncaut, N., Siligan, C., Taylor, K., Cross, J.W., Rigby, P.W., and
Carvajal, J.J. (2011). Members of the TEAD family of transcription factors regu-
late the expression of Myf5 in ventral somitic compartments. Dev. Biol. 355,
372–380.
Sato, T., Rocancourt, D., Marques, L., Thorsteinsdo´ttir, S., and Buckingham,
M. (2010). A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of
myogenesis. PLoS Genet. 6, e1000897.
Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and
Rudnicki, M.A. (2000). Pax7 is required for the specification of myogenic satel-
lite cells. Cell 102, 777–786.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L.,
Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., and
Mesirov, J.P. (2005). Gene set enrichment analysis: a knowledge-based
approach for interpreting genome-wide expression profiles. Proc. Natl.
Acad. Sci. USA 102, 15545–15550.ental Cell 22, 1208–1220, June 12, 2012 ª2012 Elsevier Inc. 1219
Developmental Cell
Distinct Function of Pax7 in Adult MyogenesisSummerbell, D., Ashby, P.R., Coutelle, O., Cox, D., Yee, S., and Rigby, P.W.
(2000). The expression of Myf5 in the developing mouse embryo is controlled
by discrete and dispersed enhancers specific for particular populations of
skeletal muscle precursors. Development 127, 3745–3757.
Sun, H., Li, L., Vercherat, C., Gulbagci, N.T., Acharjee, S., Li, J., Chung, T.K.,
Thin, T.H., and Taneja, R. (2007). Stra13 regulates satellite cell activation by
antagonizing Notch signaling. J. Cell Biol. 177, 647–657.
Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis of micro-
arrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA
98, 5116–5121.1220 Developmental Cell 22, 1208–1220, June 12, 2012 ª2012 ElsevWilson, D., Sheng, G., Lecuit, T., Dostatni, N., and Desplan, C. (1993).
Cooperative dimerization of paired class homeo domains on DNA. Genes
Dev. 7, 2120–2134.
Zammit, P.S., Golding, J.P., Nagata, Y., Hudon, V., Partridge, T.A., and
Beauchamp, J.R. (2004). Muscle satellite cells adopt divergent fates: a mech-
anism for self-renewal? J. Cell Biol. 166, 347–357.
Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E.,
Nusbaum, C., Myers, R.M., Brown, M., Li, W., and Liu, X.S. (2008). Model-
based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137.ier Inc.
